March 9 (Reuters) - The U.S. health regulator issued a draft guidance on Monday to help drugmakers develop cheaper versions ...

The Trump administration launched a drug pricing initiative offering immediate savings, but experts debated whether lower ...

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

The U.S. Food and Drug Administration today announced another major step in its initiative to streamline the development of biosimilar medicines, ...

Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Charles River Laboratories ...

Many diseases in animals go untreated because of high development costs and limited markets, according to a federal report. Goats and sheep, for example, lack approved drugs to treat parasites. The ...

Find out how self-driving labs utilise data-driven approaches to enhance drug discovery efficiency and innovation.

Rare Disease Day is held on the last day of February to raise awareness for rare diseases and address drug development ...

Today Technomark Life Sciences ( and MAX BioPharma ( announced their collaboration in the development of MAX BioPharma's oxysterol drug candidate, Oxy210, for targeting ...

Ron Lanton, Senior Partner & Global Strategist, Lanton, Lanton & Sosa Law PLLC, discusses FDA’s removal of the two-trial requirement marking a significant policy shift and prompting sponsors to ...